Click for best price
Active Transdermal Drug Delivery Device Market Size, Share 2022
This report contains market size and forecasts of Active Transdermal Drug Delivery Device in global, including the following market information:
Global Active Transdermal Drug Delivery Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Transdermal Drug Delivery Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Active Transdermal Drug Delivery Device companies in 2021 (%)
The global Active Transdermal Drug Delivery Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patches Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Transdermal Drug Delivery Device include Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Corp., Johnson & Johnson (Janssen Pharmaceuticals Inc.), Mylan N.V., 3M, Actavis, Inc., Bayer AG and Boehringer Ingelheim GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Active Transdermal Drug Delivery Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Transdermal Drug Delivery Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, by Type, 2021 (%)
Patches
Gels
Global Active Transdermal Drug Delivery Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Home Use
Global Active Transdermal Drug Delivery Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Transdermal Drug Delivery Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Active Transdermal Drug Delivery Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Transdermal Drug Delivery Device revenues share in global market, 2021 (%)
Key companies Active Transdermal Drug Delivery Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Active Transdermal Drug Delivery Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
| Report Attributes |
Report Details |
| Report Title |
Active Transdermal Drug Delivery Device Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Active Transdermal Drug Delivery Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Transdermal Drug Delivery Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Active Transdermal Drug Delivery Device Overall Market Size
2.1 Global Active Transdermal Drug Delivery Device Market Size: 2021 VS 2028
2.2 Global Active Transdermal Drug Delivery Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Active Transdermal Drug Delivery Device Sales: 2017-2028
3 Company Landscape
3.1 Top Active Transdermal Drug Delivery Device Players in Global Market
3.2 Top Global Active Transdermal Drug Delivery Device Companies Ranked by Revenue
3.3 Global Active Transdermal Drug Delivery Device Revenue by Companies
3.4 Global Active Transdermal Drug Delivery Device Sales by Companies
3.5 Global Active Transdermal Drug Delivery Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Active Transdermal Drug Delivery Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Active Transdermal Drug Delivery Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Transdermal Drug Delivery Device Players in Global Market
3.8.1 List of Global Tier 1 Active Transdermal Drug Delivery Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Transdermal Drug Delivery Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Active Transdermal Drug Delivery Device Market Size Markets, 2021 & 2028
4.1.2 Patches
4.1.3 Gels
4.2 By Type - Global Active Transdermal Drug Delivery Device Revenue & Forecasts
4.2.1 By Type - Global Active Transdermal Drug Delivery Device Revenue, 2017-2022
4.2.2 By Type - Global Active Transdermal Drug Delivery Device Revenue, 2023-2028
4.2.3 By Type - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
4.3 By Type - Global Active Transdermal Drug Delivery Device Sales & Forecasts
4.3.1 By Type - Global Active Transdermal Drug Delivery Device Sales, 2017-2022
4.3.2 By Type - Global Active Transdermal Drug Delivery Device Sales, 2023-2028
4.3.3 By Type - Global Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
4.4 By Type - Global Active Transdermal Drug Delivery Device Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Active Transdermal Drug Delivery Device Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Home Use
5.2 By Application - Global Active Transdermal Drug Delivery Device Revenue & Forecasts
5.2.1 By Application - Global Active Transdermal Drug Delivery Device Revenue, 2017-2022
5.2.2 By Application - Global Active Transdermal Drug Delivery Device Revenue, 2023-2028
5.2.3 By Application - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
5.3 By Application - Global Active Transdermal Drug Delivery Device Sales & Forecasts
5.3.1 By Application - Global Active Transdermal Drug Delivery Device Sales, 2017-2022
5.3.2 By Application - Global Active Transdermal Drug Delivery Device Sales, 2023-2028
5.3.3 By Application - Global Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
5.4 By Application - Global Active Transdermal Drug Delivery Device Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Active Transdermal Drug Delivery Device Market Size, 2021 & 2028
6.2 By Region - Global Active Transdermal Drug Delivery Device Revenue & Forecasts
6.2.1 By Region - Global Active Transdermal Drug Delivery Device Revenue, 2017-2022
6.2.2 By Region - Global Active Transdermal Drug Delivery Device Revenue, 2023-2028
6.2.3 By Region - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
6.3 By Region - Global Active Transdermal Drug Delivery Device Sales & Forecasts
6.3.1 By Region - Global Active Transdermal Drug Delivery Device Sales, 2017-2022
6.3.2 By Region - Global Active Transdermal Drug Delivery Device Sales, 2023-2028
6.3.3 By Region - Global Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Active Transdermal Drug Delivery Device Revenue, 2017-2028
6.4.2 By Country - North America Active Transdermal Drug Delivery Device Sales, 2017-2028
6.4.3 US Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.4.4 Canada Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.4.5 Mexico Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Active Transdermal Drug Delivery Device Revenue, 2017-2028
6.5.2 By Country - Europe Active Transdermal Drug Delivery Device Sales, 2017-2028
6.5.3 Germany Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.5.4 France Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.5.5 U.K. Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.5.6 Italy Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.5.7 Russia Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.5.8 Nordic Countries Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.5.9 Benelux Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Active Transdermal Drug Delivery Device Revenue, 2017-2028
6.6.2 By Region - Asia Active Transdermal Drug Delivery Device Sales, 2017-2028
6.6.3 China Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.6.4 Japan Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.6.5 South Korea Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.6.6 Southeast Asia Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.6.7 India Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Active Transdermal Drug Delivery Device Revenue, 2017-2028
6.7.2 By Country - South America Active Transdermal Drug Delivery Device Sales, 2017-2028
6.7.3 Brazil Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.7.4 Argentina Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales, 2017-2028
6.8.3 Turkey Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.8.4 Israel Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.8.5 Saudi Arabia Active Transdermal Drug Delivery Device Market Size, 2017-2028
6.8.6 UAE Active Transdermal Drug Delivery Device Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Active Transdermal Drug Delivery Device Major Product Offerings
7.1.4 Novartis AG Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.1.5 Novartis AG Key News
7.2 Noven Pharmaceuticals, Inc.
7.2.1 Noven Pharmaceuticals, Inc. Corporate Summary
7.2.2 Noven Pharmaceuticals, Inc. Business Overview
7.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.2.5 Noven Pharmaceuticals, Inc. Key News
7.3 Transdermal Corp.
7.3.1 Transdermal Corp. Corporate Summary
7.3.2 Transdermal Corp. Business Overview
7.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Major Product Offerings
7.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.3.5 Transdermal Corp. Key News
7.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporate Summary
7.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
7.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Major Product Offerings
7.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News
7.5 Mylan N.V.
7.5.1 Mylan N.V. Corporate Summary
7.5.2 Mylan N.V. Business Overview
7.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Major Product Offerings
7.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.5.5 Mylan N.V. Key News
7.6 3M
7.6.1 3M Corporate Summary
7.6.2 3M Business Overview
7.6.3 3M Active Transdermal Drug Delivery Device Major Product Offerings
7.6.4 3M Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.6.5 3M Key News
7.7 Actavis, Inc.
7.7.1 Actavis, Inc. Corporate Summary
7.7.2 Actavis, Inc. Business Overview
7.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.7.5 Actavis, Inc. Key News
7.8 Bayer AG
7.8.1 Bayer AG Corporate Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Active Transdermal Drug Delivery Device Major Product Offerings
7.8.4 Bayer AG Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.8.5 Bayer AG Key News
7.9 Boehringer Ingelheim GmbH
7.9.1 Boehringer Ingelheim GmbH Corporate Summary
7.9.2 Boehringer Ingelheim GmbH Business Overview
7.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Major Product Offerings
7.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.9.5 Boehringer Ingelheim GmbH Key News
7.10 Corium International, Inc.
7.10.1 Corium International, Inc. Corporate Summary
7.10.2 Corium International, Inc. Business Overview
7.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.10.5 Corium International, Inc. Key News
7.11 Echo Therapeutics, Inc.
7.11.1 Echo Therapeutics, Inc. Corporate Summary
7.11.2 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Business Overview
7.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Major Product Offerings
7.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.11.5 Echo Therapeutics, Inc. Key News
7.12 GlaxoSmithKline plc
7.12.1 GlaxoSmithKline plc Corporate Summary
7.12.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Business Overview
7.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Major Product Offerings
7.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales and Revenue in Global (2017-2022)
7.12.5 GlaxoSmithKline plc Key News
8 Global Active Transdermal Drug Delivery Device Production Capacity, Analysis
8.1 Global Active Transdermal Drug Delivery Device Production Capacity, 2017-2028
8.2 Active Transdermal Drug Delivery Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Transdermal Drug Delivery Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Active Transdermal Drug Delivery Device Supply Chain Analysis
10.1 Active Transdermal Drug Delivery Device Industry Value Chain
10.2 Active Transdermal Drug Delivery Device Upstream Market
10.3 Active Transdermal Drug Delivery Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Transdermal Drug Delivery Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Active Transdermal Drug Delivery Device in Global Market
Table 2. Top Active Transdermal Drug Delivery Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Active Transdermal Drug Delivery Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Active Transdermal Drug Delivery Device Revenue Share by Companies, 2017-2022
Table 5. Global Active Transdermal Drug Delivery Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Active Transdermal Drug Delivery Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Active Transdermal Drug Delivery Device Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Active Transdermal Drug Delivery Device Product Type
Table 9. List of Global Tier 1 Active Transdermal Drug Delivery Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Transdermal Drug Delivery Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Active Transdermal Drug Delivery Device Sales (K Units), 2017-2022
Table 15. By Type - Global Active Transdermal Drug Delivery Device Sales (K Units), 2023-2028
Table 16. By Application ? Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Active Transdermal Drug Delivery Device Sales (K Units), 2017-2022
Table 20. By Application - Global Active Transdermal Drug Delivery Device Sales (K Units), 2023-2028
Table 21. By Region ? Global Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Active Transdermal Drug Delivery Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Active Transdermal Drug Delivery Device Sales (K Units), 2017-2022
Table 25. By Region - Global Active Transdermal Drug Delivery Device Sales (K Units), 2023-2028
Table 26. By Country - North America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Active Transdermal Drug Delivery Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Active Transdermal Drug Delivery Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Active Transdermal Drug Delivery Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Active Transdermal Drug Delivery Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Active Transdermal Drug Delivery Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Active Transdermal Drug Delivery Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Active Transdermal Drug Delivery Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Active Transdermal Drug Delivery Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales, (K Units), 2023-2028
Table 46. Novartis AG Corporate Summary
Table 47. Novartis AG Active Transdermal Drug Delivery Device Product Offerings
Table 48. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Noven Pharmaceuticals, Inc. Corporate Summary
Table 50. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 51. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Transdermal Corp. Corporate Summary
Table 53. Transdermal Corp. Active Transdermal Drug Delivery Device Product Offerings
Table 54. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporate Summary
Table 56. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Offerings
Table 57. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Mylan N.V. Corporate Summary
Table 59. Mylan N.V. Active Transdermal Drug Delivery Device Product Offerings
Table 60. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. 3M Corporate Summary
Table 62. 3M Active Transdermal Drug Delivery Device Product Offerings
Table 63. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Actavis, Inc. Corporate Summary
Table 65. Actavis, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 66. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bayer AG Corporate Summary
Table 68. Bayer AG Active Transdermal Drug Delivery Device Product Offerings
Table 69. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Boehringer Ingelheim GmbH Corporate Summary
Table 71. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Offerings
Table 72. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Corium International, Inc. Corporate Summary
Table 74. Corium International, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 75. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Echo Therapeutics, Inc. Corporate Summary
Table 77. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Offerings
Table 78. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. GlaxoSmithKline plc Corporate Summary
Table 80. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Offerings
Table 81. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Active Transdermal Drug Delivery Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Active Transdermal Drug Delivery Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Active Transdermal Drug Delivery Device Production by Region, 2017-2022 (K Units)
Table 85. Global Active Transdermal Drug Delivery Device Production by Region, 2023-2028 (K Units)
Table 86. Active Transdermal Drug Delivery Device Market Opportunities & Trends in Global Market
Table 87. Active Transdermal Drug Delivery Device Market Drivers in Global Market
Table 88. Active Transdermal Drug Delivery Device Market Restraints in Global Market
Table 89. Active Transdermal Drug Delivery Device Raw Materials
Table 90. Active Transdermal Drug Delivery Device Raw Materials Suppliers in Global Market
Table 91. Typical Active Transdermal Drug Delivery Device Downstream
Table 92. Active Transdermal Drug Delivery Device Downstream Clients in Global Market
Table 93. Active Transdermal Drug Delivery Device Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Active Transdermal Drug Delivery Device Segment by Type
Figure 2. Active Transdermal Drug Delivery Device Segment by Application
Figure 3. Global Active Transdermal Drug Delivery Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Active Transdermal Drug Delivery Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Active Transdermal Drug Delivery Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Active Transdermal Drug Delivery Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Active Transdermal Drug Delivery Device Revenue in 2021
Figure 9. By Type - Global Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Active Transdermal Drug Delivery Device Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Active Transdermal Drug Delivery Device Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 19. US Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 24. Germany Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 33. China Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 40. Brazil Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Active Transdermal Drug Delivery Device Sales Market Share, 2017-2028
Figure 44. Turkey Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Active Transdermal Drug Delivery Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Active Transdermal Drug Delivery Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Active Transdermal Drug Delivery Device by Region, 2021 VS 2028
Figure 50. Active Transdermal Drug Delivery Device Industry Value Chain
Figure 51. Marketing Channels
